[Imiquimod in treatment of palpebral mycosis fungoides].
METHODS
Our patient was a 37-year-old male with palpebral mycosis fungoides, the most common T-cell cutaneous lymphoma. He had been treated previously with topical corticosteroids. We treated him with Imiquimod cream (5%) three times a week.


CONCLUSIONS
A clinical improvement was obtained with this drug, so we believe immuno-modulating agents need to be considered in the treatment of palpebral mycosis fungoides, especially because of its capacity of being a reflection of leukaemia.
Soler-Machín
J
J
Servicio de Oftalmología, Hospital General San Jorge, Huesca, España. javiersolermachin@hotmail.com
Gilaberte-Calzada
Y
Y
Vera-Alvarez
J
J
Coscojuela-Santaliestra
C
C
Martínez-Morales
J
J
Osán-Tello
M
M